Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session

Author(s):: Deken, M.M.; Kijanka, M.M.; Hernandez, I.B.; Slooter, M.D.; Bruijn, H.S. de; Diest, P.J. van; Henegouwen, P.M.P.V.; Lowik, C.W.G.M.; Robinson, D.J.; Vahrmeijer, A.L. (0000-0001-9370-0011); Oliveira, S.

Published: 2020
Publication type: Article / Letter to editor

Date issued: 2020-07-10
Language: English
Publisher: ELSEVIER
Is part of: Journal of Controlled Release (2020), Vol. 323, p. 269-281
hdl: 1887/3182191
doi: 10.1016/j.jconrel.2020.04.030
URL: https://www.sciencedirect.com/science/article/pii/S0168365920302443?via%3Dihub